Global Complementary And Alternative Medicine Market
Global Complementary And Alternative Medicine Market Projected to Reach USD 192.41 Billion by 2028, Growing at a CAGR of 12.1%
28 mars 2024 10h36 HE | Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Complementary And Alternative Medicine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ...
Global Complementary and Alternative Medicine Market
Global Complementary and Alternative Medicine Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
13 juin 2022 07h33 HE | Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Complementary and Alternative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added...
22157.jpg
Global $190 Billion Botanicals & Acupuncture Market Outlook to 2027
14 janv. 2021 08h03 HE | Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Botanicals & Acupuncture - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Botanicals &...
22157.jpg
Global $190.66 Bn Botanicals & Acupuncture Market Outlook to 2027
05 janv. 2021 08h53 HE | Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Botanicals & Acupuncture - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Botanicals &...
22157.jpg
Global Botanicals & Acupuncture Markets 2019-2020 & 2027 - Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations
06 nov. 2020 04h18 HE | Research and Markets
Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Botanicals & Acupuncture - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global botanicals &...
MateonLogo.jpg
MATEON TO PARTICIPATE IN BIO INVESTOR FORUM DIGITAL
12 oct. 2020 08h00 HE | Mateon Therapeutics, Inc.
AGOURA HILLS, California, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, today announced...